MichaelJSampsonDOFAOASM

PubMed

• 485 citations
  Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge
  Richa Saxena, Claudia Langenberg, Toshiko Tanaka, James S. Pankow, Peter Vollenweider, Valeriya Lyssenko, Nabila Bouatia-Naji, Josée Dupuis, Anne U. Jackson, W. H. Lin...> ;Nature Genetics. 2010 Feb 1
• 1671 citations
  New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
  Josée Dupuis, Claudia Langenberg, Inga Prokopenko, Richa Saxena, Nicole Soranzo, Anne U. Jackson, Eleanor Wheeler, Nicole L. Glazer, Nabila Bouatia-Naji, Anna L. Gloyn...> ;Nature Genetics. 2010 Feb 1
• Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes.
  Sampson, M.J., Gopaul, N., Davies, I.R., Hughes, D.A., Carrier, M.J.> ;Diabetes Care. 2002 Mar
• Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study.
  Taylor R, Davies R, Fox C, Sampson M, Weaver JU, Wood L> ;Diabetes Care. 2000-11-01
• Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes.
  Astley S, Langrish-Smith A, Southon S, Sampson M> ;Diabetes Care. 1999-10-01
• Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group.
  Keen H, Payan J, Allawi J, Walker J, Jamal GA, Weir AI, Henderson LM, Bissessar EA, Watkins PJ, Sampson M> ;Diabetes Care. 1993-01-01
• 48 citations
  Accurate Estimation of Glomerular Filtration Rate in Diabetic Nephropathy From Age, Body Weight, and Serum Creatinine
  Mike Sampson, Paul L. Drury> ;Diabetes Care. 1992 May 1
• Prevention of diabetic nephropathy with enalapril.
  Pickering S, Sampson M, Foyle W, Drury P> ;BMJ. 1988-12-17
• Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study.
  Temple, R., Aldridge, V., Greenwood, R., Heyburn, P., Sampson, M., Stanley, K.> ;BMJ. 2002 Nov 30
• Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis.
  Voight, B. F., Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., Zeggini, E., Huth, C., Aulchenko, Y. S., Thorleifsson, G., McCulloch, L. J., ...> ;Nat Genet. 2010 Jul
• Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes.
  Sampson, M. J., Davies, I. R., Braschi, S., Ivory, K., Hughes, D. A.> ;Atherosclerosis. 2003 Mar
• Join now to see all